Volume 51, Issue 6, Pages (December 2009)

Slides:



Advertisements
Similar presentations
EASL Clinical Practice Guidelines: Vascular diseases of the liver Journal of Hepatology Volume 64, Issue 1, Pages (January 2016) DOI: /j.jhep
Advertisements

Depression, anemia and health-related quality of life in chronic hepatitis C Amy A. Dan, Lisa M. Martin, Cathy Crone, Janus P. Ong, Denise W. Farmer, Thomas.
Omega 3 – Omega 6: What is right for the liver? Ashraf Mohammad El-Badry, Rolf Graf, Pierre-Alain Clavien Journal of Hepatology Volume 47, Issue 5, Pages.
Volume 63, Issue 1, Pages (July 2015)
Volume 53, Issue 1, Pages (July 2010)
Volume 46, Issue 3, Pages (March 2007)
The impact of hepatitis E in the liver transplant setting
Inflammasomes in liver diseases
Volume 61, Issue 4, Pages (October 2014)
Volume 50, Issue 4, Pages (April 2009)
Lifestyle interventions for the treatment of non-alcoholic fatty liver disease in adults: A systematic review  Christian Thoma, Christopher P. Day, Michael.
Volume 67, Issue 2, Pages (August 2017)
Julien Bissonnette, Dominique Valla, Pierre-Emmanuel Rautou 
Volume 61, Issue 6, Pages (December 2014)
Halis Simsek, Ali Shorbagi, Yasemin Balaban, Gonca Tatar 
The impact of hepatitis E in the liver transplant setting
Reactive oxygen species in the normal and acutely injured liver
Matthew T. Kitson, Stuart K. Roberts  Journal of Hepatology 
NS5A inhibitors in the treatment of hepatitis C
Immigration and viral hepatitis
Virological tools to diagnose and monitor hepatitis C virus infection
Volume 66, Issue 1, Pages 1-4 (January 2017)
Living donor liver transplantation: is the hype over?
Volume 69, Issue 2, Pages (August 2018)
Volume 44, Pages S19-S24 (January 2006)
Natural history and predictors of severity of chronic hepatitis C virus (HCV) and human immunodeficiency virus (HIV) co-infection  Anaïs Vallet-Pichard,
The place of downstaging for hepatocellular carcinoma
Cheng-Yuan Peng, Rong-Nan Chien, Yun-Fan Liaw  Journal of Hepatology 
Hepatitis C core protein – The “core” of immune deception?
Volume 61, Issue 1, Pages S108-S119 (November 2014)
Marc van der Valk, Hans L. Zaaijer, Arnon P. Kater, Janke Schinkel 
Amalia Gastaldelli, Giulio Marchesini  Journal of Hepatology 
Volume 70, Issue 1, Pages (January 2019)
Statin use and the risk of hepatocellular carcinoma in patients at high risk: A nationwide nested case-control study  Gyuri Kim, Suk-Yong Jang, Chung.
Volume 61, Issue 1, Pages S69-S78 (November 2014)
Volume 62, Issue 3, Pages (March 2015)
Genomic risk of hepatitis C-related hepatocellular carcinoma
Darius Moradpour, Arash Grakoui, Michael P. Manns 
Autophagy in the liver Journal of Hepatology
Behzad Hajarizadeh, Jason Grebely, Gregory J. Dore 
EASL Clinical Practice Guidelines: Wilson’s disease
Volume 61, Issue 1, Pages S45-S57 (November 2014)
Economics of chronic hepatitis B and hepatitis C
Volume 65, Issue 2, Pages (August 2016)
Rafael Esteban, Maria Buti  Gastroenterology 
Volume 59, Issue 4, Pages (October 2013)
Volume 50, Issue 4, Pages (April 2009)
Antiviral therapy for chronic hepatitis B: Challenges in Hong Kong
Paul C. Adams, James C. Barton  Journal of Hepatology 
Volume 70, Issue 1, Pages (January 2019)
Volume 56, Issue 6, Pages (June 2012)
Volume 50, Issue 3, Pages (March 2009)
Immigration and viral hepatitis
Clinical Practice Guidelines of the European Association for the study of the Liver – Advancing methodology but preserving practicability  Markus Cornberg,
HCV targeting of patients with cirrhosis
Immunological techniques in viral hepatitis
Volume 63, Issue 1, Pages (July 2015)
Familial amyloidosis: Great progress for an orphan disease
Volume 51, Issue 2, Pages (August 2009)
Hepatitis C infection: A multi-faceted systemic disease with clinical, patient reported and economic consequences  Zobair M. Younossi, Aybike Birerdinc,
The use of hemospray in portal hypertensive bleeding; a case series
Volume 62, Issue 3, Pages (March 2015)
Reviewer Acknowledgment
New trials and results in systemic treatment of HCC
Liver transplantation in children
Pathogenesis of cholestatic hepatitis C
Chimeric mouse model of hepatitis B virus infection
Volume 54, Issue 6, Pages (June 2011)
The relationship between age and fat infiltration in liver and muscle
Reversion of disease manifestations after HCV eradication
Presentation transcript:

Volume 51, Issue 6, Pages 1091-1096 (December 2009) Successful use of entecavir for a severe case of reactivation of hepatitis B virus following polychemotherapy containing rituximab  Mayra J. Sanchez, Maria Buti, Maria Homs, Andres Palacios, Francisco Rodriguez-Frias, Rafael Esteban  Journal of Hepatology  Volume 51, Issue 6, Pages 1091-1096 (December 2009) DOI: 10.1016/j.jhep.2009.07.012 Copyright © 2009 European Association for the Study of the Liver Terms and Conditions

Fig. 1 Biochemical parameters before and during entecavir treatment. Journal of Hepatology 2009 51, 1091-1096DOI: (10.1016/j.jhep.2009.07.012) Copyright © 2009 European Association for the Study of the Liver Terms and Conditions

Fig. 2 Virologic parameters before and during entecavir treatment. Journal of Hepatology 2009 51, 1091-1096DOI: (10.1016/j.jhep.2009.07.012) Copyright © 2009 European Association for the Study of the Liver Terms and Conditions

Feedback: Privacy Policy Feedback
Do Not Sell My Personal Information
About project: SlidePlayer Terms of Service

© 2025 SlidePlayer.com. Inc. All rights reserved.